A Multiple-dose Study in Chinese Subjects to Evaluate Safety,Tolerability,PK and PD of ZM-H1505R

NCT05470829 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Hepatitis B, Chronic

Interventions

DRUG: ZM-H1505R
OTHER: ZM-H1505R Placebo

Sponsor

Shanghai Zhimeng Biopharma, Inc.